FORT LAUDERDALE, Fla., June 4, 2012 /PRNewswire/ -- Nouveau Life Pharmaceuticals Inc. (Pink Sheets: NOUV), a leading provider of quality all-natural dietary supplements, announced today the release of its newest supplement product: New Life Naturals: For Your Weight Loss'.
The For Your Weight Loss' supplement was developed by Nouveau Life as a dietary aid for the more than one-third of U.S. adults who are now considered obese (Source: Centers for Disease Control & Prevention). The weight loss supplement is a Raspberry Ketone Formula with Acai. Recently recommended by Dr. Oz, Raspberry Ketones cause the body to burn fat faster and more effectively. When taken in conjunction with regular exercise and a well-balanced diet, For Your Weight Loss' can help to shed pounds quickly.
"The addition of a weight loss supplement to our New Life Naturals' product line fit into our strategy for growing Nouveau Life, which - in simple terms - is to address real health concerns in profitable markets. Obesity is a major health concern for a large part of the U.S. population. The For Your Weight Loss' product is a safe, all-natural alternative to side effect-laden prescription medications. And the market for over-the-counter weight loss aids is growing at a nice clip," explained Nouveau Life CEO Melissa Walker.
According to Marketdata forecasts, annual sales of meal replacements and OTC diet pills sales should realize a 3.3% growth by 2014 in the U.S., raising the combined market value to an estimated $3.04 billion by that time.
New Life Naturals: For Your Weight Loss' is the second product to be released in Nouveau Life's signature New Life Naturals' line of quality, all-natural dietary supplements. The weight loss supplement can currently be purchased by visiting www.nlpnaturals.com.
About Nouveau Life Pharmaceuticals
The Company, formerly known as Hybrid Fuels, Inc., was incorporated in the state ofNevadain 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunitiesand further advancing technologies.
Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Nouveau Life Pharmaceuticals, Inc. undertakes no obligation to update such statements.
Nouveau Life Pharmaceuticals, Inc. - 954-903-2993
SOURCE Nouveau Life Pharmaceuticals, Inc.